About Us

An effective antenatal and newborn screening programme means supporting the whole journey from the offer of a screening test through to the availabilty of quality care.  Read our Programme Profile which gives a picture of the Screening Programme's aims, objectives and values.

You can also read about what we mean by a linked programme.

 

1. The NHS Plan

The NHS Sickle Cell and Thalassaemia (SC&T) Screening Programme was set up in England in 2001 following Government commitment in the NHS Plan* (2000). It is the world's first linked antenatal and newborn screening programme.

* to implement "… effective and appropriate screening programmes for women and children including a new national linked antenatal and neonatal screening programme for haemoglobinopathy and sickle cell disease by 2004…"

 

2. The aims of the screening programme

  • Support people to make informed choices during pregnancy and before conception.
  • Improve infant health through prompt identification of affected babies.
  • Provide high quality and accessible care throughout England.
  • Promote greater understanding and awareness of the disorders and the value of screening.
  •  

    3. Care

    The Programme is working with the Department of Health to develop managed clinical care networks and support of those affected by sickle cell and thalassaemia.  Managed care is not only important in relieving suffering, but also cost-effective in reducing the cost of specialist interventions.  Many of the strategies planned will help families to spot warning signs and take early action.  This, in turn, will reduce complications that are more expensive for the NHS in the longer term.

     

    4. Programme team

    Programme Director Dr Allison Streetly
    EA to Programme Director Nelly Jackson

    Deputy Programme Director

    Programme Business Manager

    Dr Elizabeth Dormandy

    Dr Patricia Connell

    Programme Administrator Jessamy Willson-Pepper
    Data Analyst Matthew Charlton
    Clinical Data Co-ordinator

    Radoslav Latinovic

    Quality improvement

    Quality Improvement Lead Dr Elizabeth Dormandy

     

     

    Quality Improvement Co-ordinator Priya Omahadat
    Quality Improvement Co-ordinator   to be appointed

    Communications

    Communications Manager Claire Laurent
    Communications Officer
    Kemi Johnson

    External consultants

    Community engagement and communications         Elizabeth Aram
    IT  Heather Develin
    Implementation  Cynthia Gill
    Laboratory  Dr Yvonne Daniel

    Laboratory 

    Joan Henthorn

    Laboratory  Dr David Worthington
    Finance  Roma Haigh

     

    5. Steering Group membership

    Chair

    The Most Rev & Rt Hon Dr John Sentamu


    Vice Chair

    Dr Paul Telfer

     

    Professional Groups

       
    Professor Elizabeth Anionwu   National Screening Committee, Antenatal Subgroup
      and Emeritus Professor of Nursing,
      Thames Valley University
    Ms Sarah Cromwell   Screening Policy Manager, Department of Health
    Ms Janet Fyle   Director of Midwifery Affairs, Royal College of
      Midwives
    Ms Joan Henthorn   Co-Director of Neonatal Screening Laboratory,
      Central Middlesex Hospital
    Ms Jane Hibbert   Regional Antenatal Coordinators
    Dr Tracey Johnston   Consultant Obstetrician Manchester
    Gulsan Karbani   Genetic Counsellor and Research Fellow, Leeds
    Professor Theresa Marteau   Professor of Health Psychology Institute of Psychiatry
    Dr Ruth Newbury-Ecob   Consultant in Clinical Genetics, St Michaels Hospital
    Dr Lola Oni OBE   STAC, The Haemoglobinopathy Association of
      Counsellors
    Dr Anne Yardumian   Consultant Haematologist UK Forum on Haemoglobin Disorders

    Voluntary Sector

    Elaine Miller           United Kingdom Thalassaemia Society
    Dr Phillip Nortey           Sickle Cell Society
    Dr Christos Sotirelis           United Kingdom Thalassaemia Society
    Anne Welsh           Sickle Cell Society

    Users/ Patient Representatives

    Abim Mabadeje     Patient Representative Sickle Cell
    Victor Onikepe     Patient Representative Sickle Cell
    Sonoo Malkani     Patient Representative Thalassaemia
    Anthony Mason     Patient Representative Sickle Cell
    Carol Nwosu     Patient Representative Sickle Cell
    Zanib Rasul     Patient Representative Thalassaemia
    Sayed Mahmud Rahman     Patient Representative Thalassaemia
       

    Expert Advisors

    Dr Claire Chapman       Expert Adviser - General Haemoglobinopathies
    Dr Jane Logan       General Practitioner, London
    Dr John Old       Clincal Scientist, Oxford

    Observers

    Dr Margaret Boyle    DH Social Services and Public Policy,
       Northern Ireland
    Rosemary Johnson    Wales Antenatal Screening Project
    Dr Vinod Devalia    Wales Antenatal Screening Project
    Dr Catherine Calderwood    Scottish Executive

     

    6. Watch Dr Allison Streetly speak about the Screening Programme

    Watch a short introduction to the programme from Dr Allison Streetly, Programme Director.

     

    Related items

     

    Current publications

    page image